BA$217.11–0.07%LMT$514.99▼0.65%NOC$545.11▼0.17%RTX$195.20▲0.62%GD$372.78▼0.81%LHX$288.69▼1.16%RKLB$76.73▼3.96%PL$25.96–0.00%JOBY$7.48▼0.80%ACHR$4.85▲5.21%SPCE$2.61▲4.61%KTOS$49.68▼4.07%BA$217.11–0.07%LMT$514.99▼0.65%NOC$545.11▼0.17%RTX$195.20▲0.62%GD$372.78▼0.81%LHX$288.69▼1.16%RKLB$76.73▼3.96%PL$25.96–0.00%JOBY$7.48▼0.80%ACHR$4.85▲5.21%SPCE$2.61▲4.61%KTOS$49.68▼4.07%

Slice of Aerospace

Space & LaunchDefense & MilitaryCommercial AviationDrones & AutonomyeVTOL & Urban Air

Search

Search across companies, people, and content

SubscribeSign In

Editions

  • Commercial Aviation
  • Defense & Military
  • Drones & Autonomy
  • eVTOL & Urban Air
  • Space & Launch

Content

  • Articles
  • Podcast
  • Newsletters
  • Thoughts
  • Debates

Intelligence

  • Companies
  • People
  • Rankings
  • Awards
  • Predictions

Community

  • Subscribe
  • About
  • Events
  • Network

Slice Network

  • Construction
  • Finance
  • Healthcare
  • Hospitality
  • Maritime

© 2026 Slice of Aerospace. A Slice of Media publication.

/
/
Slice of Aerospace/Companies/Eli Lilly and Company
E

Eli Lilly and Company

Pharmaceutical company presenting research on AD blood testing cost-effectiveness

pharmabiotechhealthcarediagnostics

People at Eli Lilly and Company

D
Dr. Anthony Nino SireciSenior Vice President of Clinical Biomarkers, Laboratories, and Diagnostics

Signals

Eli Lilly presented new data on cost-effectiveness of AD blood testing at AD/PD 2026 conference

launchMar 26, 2026$5K

Eli Lilly and Company presented new data on cost-effectiveness of AD blood testing at AD/PD 2026 conference

otherMar 26, 2026

Coverage

No published content mentioning Eli Lilly and Company yet